Citadel Advisors - ODONATE THERAPEUTICS INC ownership

ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 95 filers reported holding ODONATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ODONATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$44,000
-84.3%
32,797
-65.9%
0.00%
Q3 2021$280,000
-70.2%
96,265
-64.3%
0.00%
Q2 2021$941,000
-30.3%
269,489
-31.8%
0.00%
Q1 2021$1,351,000
-64.4%
394,964
+99.9%
0.00%
Q4 2020$3,795,000
+2.4%
197,613
-28.3%
0.00%
Q3 2020$3,705,000
+69.3%
275,795
+433.4%
0.00%
-100.0%
Q2 2020$2,189,000
+67.1%
51,705
+9.0%
0.00%0.0%
Q1 2020$1,310,000
+39.4%
47,435
+63.8%
0.00%
Q4 2019$940,000
+211.3%
28,958
+149.2%
0.00%
Q3 2019$302,000
-36.7%
11,621
-65.7%
0.00%
Q4 2018$477,00033,8850.00%
Other shareholders
ODONATE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 15,514,566$297,880,00045.48%
Boxer Capital, LLC 5,607,086$107,656,0003.46%
Samsara BioCapital, LLC 815,421$15,656,0001.57%
GSA CAPITAL PARTNERS LLP 148,148$2,844,0000.46%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,211,728$23,265,0000.38%
RTW INVESTMENTS, LP 1,000,139$19,203,0000.32%
Sio Capital Management, LLC 75,500$1,450,0000.30%
AlphaCentric Advisors LLC 29,594$568,0000.24%
Birchview Capital, LP 20,000$384,0000.22%
Aristides Capital LLC 33,226$638,0000.22%
View complete list of ODONATE THERAPEUTICS INC shareholders